Stay updated on Dupilumab in COPD Clinical Trial
Sign up to get notified when there's something new on the Dupilumab in COPD Clinical Trial page.

Latest updates to the Dupilumab in COPD Clinical Trial page
- Check3 days agoNo Change Detected
- Check11 days agoChange DetectedAdded a government operating status notice and a v3.2.0 revision tag, replacing the previous v3.1.0. This updates core content with current operating status guidance and versioning.SummaryDifference1%
- Check18 days agoChange Detected- Added version indicator Revision: v3.1.0. - Removed several substantive topics (Drug Safety, Counterfeit Drugs, Pharmaceutical Preparations, Substandard Drugs) and retained a prior version Revision: v3.0.2, suggesting a reorganization and narrowing of content scope with a move to a newer version.SummaryDifference0.2%
- Check25 days agoChange DetectedRemoved the 'Back to Top' link; no other content changes detected.SummaryDifference0.0%
- Check33 days agoChange DetectedRevision tag updated from v3.0.0-post.1-g752effb-HEAD to v3.0.2, indicating a new version release.SummaryDifference0.0%
- Check40 days agoChange DetectedThe page has updated the citation for a study on type 2 inflammation biomarkers in COPD, reflecting a new publication date and revision version.SummaryDifference0.3%
- Check47 days agoChange DetectedThe web page has added significant new content related to drug safety, publications, and specific locations, while also removing outdated location references and some drug information. Notably, the facility name and various geographical locations have been updated.SummaryDifference18%
Stay in the know with updates to Dupilumab in COPD Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Dupilumab in COPD Clinical Trial page.